Review: Plasma renin and the incidence of cardiovascular disease

Tom Meade1

  • 1INon-communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E7HT, UK. tom.meade@lshtm.ac.uk

Insights

Renin

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Epidemiology

Background:

  • The role of renin in the development of coronary heart disease (CHD) is not fully understood.
  • A 1972 case-control study suggested a link between renin and CHD.
  • Recent prospective studies have investigated this association further.

Purpose of the Study:

  • To evaluate the association between renin levels and the risk of coronary heart disease (CHD).
  • To synthesize findings from multiple prospective epidemiological studies.

Main Methods:

  • Three prospective cohort studies were analyzed: one in hypertensive subjects (New York), and two in general occupational groups (London and Framingham).
  • Studies examined the relationship between baseline renin levels and subsequent CHD incidence.
  • Participants were selected based on different criteria, including blood pressure levels.

Main Results:

  • The New York study indicated an increased CHD risk with higher renin levels in hypertensive individuals.
  • The London and Framingham studies found no significant association between renin levels and overall CHD risk.
  • A potential, though not statistically significant, association was observed in subgroups with similar blood pressure to the New York cohort.

Conclusions:

  • Current evidence provides limited support for the hypothesis that high renin levels increase the risk of coronary heart disease.
  • An uncertain exception may exist for individuals with elevated blood pressure.
  • Further research is needed to clarify the role of renin in specific hypertensive populations.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...